Trending stocks: Jubilant Life Sciences share price climbs 5%

NEW DELHI: Shares of Jubilant Life Sciences traded 4.99 per cent up in Wednesday 's trade at 10:56AM (IST).
Around 3891 shares changed hands on the counter. The stock opened at Rs 429.95 and touched an intraday high and low of Rs 429.95 and Rs 429.95 , respectively, in the session so far.

The stock quoted a 52-week high of Rs 663.35 and a 52-week low of Rs 234.35 .


The company said it has entered into a non-exclusive licensing agreement with Gilead Sciences, Inc that will grant it the right to register, manufacture and sell the latter's investigational drug, remdesivir, a potential therapy for COVID-19, in 127 countries including India.

Financials
Jubilant Life Sciences Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6825.99 Crore) operating in Pharmaceuticals sector.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 2279.89 Crore, up 1.94 % from last quarter Sales of Rs 2236.55 Crore and down -3.11 % from last year same quarter Sales of Rs 2353.08 Crore Company has reported net profit after tax of Rs 203.38 Crore in latest quarter.

Jubilant Life Sciences Ltd. key Products/Revenue Segments include Other Operating Revenue which contributed Rs 45.23 Crore to Sales Value (1.31 % of Total Sales) and Sale of services which contributed Rs 1.92 Crore to Sales Value (0.05 % of Total Sales)for the year ending 31-Mar-2019.

Promoter holding
Promoters held 46.51 per cent stake in the company as of quarter ended 31st Dec 2019 .

Valuation ratio
It quoted a price-to-earnings ratio of 12.68 and price to book value of 1.42 .